Theophylline: Nursing Drug Guide, Serum Levels & NCLEX Review
Oral extended-release methylxanthine with a narrow therapeutic window: serum theophylline above 20 mcg/mL can trigger seizures and arrhythmias. Hold additional doses for repetitive vomiting, reconcile interacting antibiotics, and treat high-fat meal spikes—not a single antidote.
Theophylline carries a narrow therapeutic index. At serum concentrations above 20 mcg/mL, adverse reactions escalate—including persistent repetitive vomiting, cardiac arrhythmias, and intractable seizures that can be lethal. Labeling directs nurses to hold additional doses whenever repetitive vomiting or other toxicity signs appear (even if another cause is suspected) and obtain a serum theophylline level immediately. Target average steady-state concentrations are 10–15 mcg/mL. New interacting drugs or a high-fat meal can push levels into the toxic range without a dose change.
📋 Contents
⚡ Quick facts
💡 Key takeaway
Before every scheduled dose, confirm recent methylxanthine exposure, new antibiotics or enzyme inhibitors, and the latest serum level. If the patient vomits repeatedly or shows new tremor, tachycardia, or confusion—hold the next dose, draw a level, and notify the prescriber/pharmacist. Never give an extra ER capsule when toxicity signs are present.
Most common brand names
Theophylline is available as immediate-release and extended-release (ER) oral products. This guide focuses on once-daily ER therapy such as Theo-24 and generic theophylline extended-release capsules/tablets.
Common presentations: Theo-24 (100, 200, 300, 400 mg capsules); generic theophylline ER tablets and capsules. Reconcile all methylxanthine sources—including IV products and combination cough/cold preparations—before titration.
Why we give it — Indications
Oral theophylline is a bronchodilator for reversible airflow obstruction in asthma and chronic obstructive pulmonary disease (COPD). It is usually adjunctive to inhaled albuterol and systemic corticosteroids such as prednisone when prescriber and guideline support methylxanthine therapy. Many patients now receive inhaled controller therapy first; oral theophylline remains an option when symptoms persist despite optimized inhaled regimens.
| Use | Detail |
|---|---|
| Chronic asthma | Symptoms and reversible airflow obstruction when inhaled therapy alone is insufficient per prescriber plan (Theo-24 labeling: chronic asthma and other chronic lung diseases). |
| COPD / chronic bronchitis / emphysema | Adjunct bronchodilator to decrease dyspnea and improve diaphragmatic function; not for acute bronchospasm—use immediate-release or inhaled rescue therapy instead. |
On a small screen, swipe or scroll sideways to see the full table.
How it works
Theophylline relaxes bronchial smooth muscle, suppresses airway hyperresponsiveness, and strengthens diaphragmatic contractility. Clinically important bronchodilation usually requires serum levels above 10 mcg/mL. Adverse CNS and cardiac effects increase when concentrations exceed 20 mcg/mL—often after drug interactions, hepatic impairment, or inconsistent high-fat meals with ER products.
Dosing overview — oral ER (adults)
Titration: Start 300–400 mg/day ER in divided or once-daily dosing per product; increase at low increments every 3 days if tolerated and sub-therapeutic. Maximum is often 600 mg/day in healthy adults; patients with risk factors (age >60, heart failure, hepatic disease) should ordinarily not exceed 400 mg/day per labeling.
Renal: No dose adjustment required in adults older than 3 months per labeling. Hepatic: Clearance may fall 50% or more in cirrhosis, acute hepatitis, or cholestasis—use lower doses and more frequent level monitoring.
Toxicity threshold: Serum theophylline >20 mcg/mL — hold additional doses for repetitive vomiting; measure levels per label schedule.
Onset, peak, duration, and half-life
| Parameter | Value | Nursing relevance |
|---|---|---|
| Therapeutic range | 10–15 mcg/mL average | Individual clearance varies up to fourfold |
| Toxic threshold | >20 mcg/mL | Seizure and arrhythmia risk increases |
| Half-life adults | ~8.7 h nonsmokers | Steady state ~1–2 days after dose change |
| High-fat meal (Theo-24) | Peak may exceed 20 mcg/mL | Keep meal pattern consistent; teach before discharge |
| Fever | Reduced clearance | Redraw level when infection or hyperthermia develops |
On a small screen, swipe or scroll sideways to see the full table.
Before you give it — Safety check
Pretreatment checks
- Complete medication reconciliation for methylxanthines, interacting antibiotics, cimetidine, phenytoin, rifampin, and smoking status changes
- Review hepatic disease, heart failure, seizure history, pregnancy, and recent dietary changes (high-fat meals with ER products)
- Obtain baseline serum theophylline when starting or after significant dose or interaction change
- Confirm correct ER product and strength; do not substitute immediate-release without prescriber/pharmacy approval
Contraindications
- Hypersensitivity to theophylline or other product components
Important interactions
| Drug / class | Effect on theophylline | Nursing action |
|---|---|---|
| Cimetidine | ~70% increase in level | Flag H2 blocker starts/stops; expect dose reduction and repeat level |
| Erythromycin | ~35% increase | Notify pharmacist when macrolide begins; monitor GI toxicity cues |
| Ciprofloxacin | ~40% increase | Common COPD exacerbation overlap—reconcile early and redraw level |
| Phenytoin | Decreased level | Symptoms may worsen if level falls; collaborate on dose adjustment |
| Rifampin | Decreased level | Anticipate sub-therapeutic levels when rifampin starts; retitrate when stopped |
On a small screen, swipe or scroll sideways to see the full table.
Administration — oral ER
- Swallow ER capsules/tablets whole; do not chew, crush, or split unless product labeling explicitly allows
- Administer Theo-24 consistently with respect to meals—labeling warns high-fat meals can spike peak levels above 20 mcg/mL
- Give at the same time each day; missed doses should not be doubled without prescriber guidance
- Separate timing from interacting drugs when pharmacy advises; document new antibiotics on the MAR the same shift
Expected therapeutic response
- Reduced wheezing and improved air entry on auscultation
- Less shortness of breath with activity; improved pulse oximetry when hypoxemia was present
- Serum theophylline trending toward 10–15 mcg/mL average; pulmonary function tests may improve over weeks in stable outpatients
Red flags — Stop and act
- Nausea or vomiting, especially repetitive—hold additional doses; draw level
- Palpitations, sustained tachycardia, or new arrhythmia when level >20 mcg/mL
- Confusion, restlessness, tremor, or seizure activity
- Level >20 mcg/mL with any toxicity sign—escalate per overdose pathway
Adverse effects
| Adverse effect | When it matters | Nursing response |
|---|---|---|
| Nausea, vomiting, insomnia, headache | Common when peak approaches 20 mcg/mL | Hold additional doses for repetitive vomiting; obtain level; notify prescriber/pharmacist |
| Tremor, restlessness, irritability | Early methylxanthine CNS stimulation | Document; correlate with level and new interactions |
| Sinus tachycardia, palpitations | More likely as levels rise | Obtain ECG if arrhythmia suspected; hold dose if toxicity likely |
| Persistent vomiting, arrhythmias, intractable seizures | Peak level >20 mcg/mL per labeling | Hold drug; emergency escalation; overdose pathway |
On a small screen, swipe or scroll sideways to see the full table.
Overdose, toxicity, and antidote
Acute overdose (excessive dose or ER formulation error) and chronic overdosage (excessive maintenance or interaction-driven accumulation) present differently. Chronic toxicity in older adults can cause seizures and arrhythmias at levels >30 mcg/mL even when peaks appear lower than massive acute ingestions.
Early signs
- Repetitive vomiting, tremor, tachycardia, restlessness—may precede seizures
- Level >20 mcg/mL: increasing arrhythmia and seizure risk
- High-fat meal with Theo-24 can acutely spike peak above 20 mcg/mL without dose change
Antidote
No specific antidote. Labeling directs: stop theophylline; supportive care with IV access, airway support, and continuous cardiac monitoring; multiple-dose activated charcoal when appropriate; benzodiazepines for seizures (phenytoin is ineffective for theophylline-induced seizures per labeling); hemodialysis or hemoperfusion for severe toxicity when seizures or arrhythmias cannot be controlled.
Contact local poison control or medical toxicology services per facility protocol when level >30 mcg/mL, toxicity signs persist, or seizures occur. Serial levels every 2–4 hours guide therapy per labeling.
Look-alike / sound-alike and error prevention
- Theophylline vs thyroxine — sound-alike confusion in verbal orders and MAR lists
- Theophylline ER vs immediate-release — different strengths and dosing intervals; verify product on every refill
- Theo-24 vs other “-24” products — confirm drug name and indication, not just suffix
- Duplicate methylxanthine therapy — oral theophylline plus IV aminophylline or theophylline-containing OTC products without level reconciliation
- Extra ER dose for wheezing flare — do not add capsules without prescriber order when level may already be therapeutic or toxic
- Strength mix-ups — 100 vs 300 vs 400 mg capsules look similar; independent double-check high-risk oral therapy
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Level timing | Draw trough before morning dose once steady state expected (~3 days after dose change); sooner if toxicity suspected |
| Meals | Keep meal fat content consistent with Theo-24; teach that restaurant high-fat meals can spike levels |
| New antibiotic | Same-shift pharmacy notification for macrolides or fluoroquinolones; schedule repeat level |
| Smoking | Smoking cessation increases levels; dose reduction may be needed |
| Commonly missed | Interaction starts on day 2–3 of antibiotic; fever slowing clearance; patient self-dosing with old IR tablets at home |
| Ask pharmacy when | Unclear ER product switch, interaction added, hepatic disease, level >20 mcg/mL, or seizure |
On a small screen, swipe or scroll sideways to see the full table.
High-risk populations
| Population | Considerations |
|---|---|
| Elderly (>60 years) | Reduced clearance and lower protein binding; maximum ordinarily 400 mg/day ER unless level-guided titration supports higher dose. |
| Hepatic impairment | Clearance decreased 50% or more—start lower, monitor levels frequently; consider unbound level when binding reduced. |
| Heart failure / cor pulmonale | Clearance reduced; use conservative titration and level monitoring at 24-hour intervals when initiating. |
| Seizure disorders | Extreme caution; underlying neurologic disease increases seizure risk at a given level. |
| Pregnancy | Pregnancy category C: no adequate controlled studies in humans. Third trimester may reduce clearance—more intensive monitoring per labeling. |
| Lactation | Theophylline is excreted into breast milk at concentrations about equivalent to maternal serum. Monitor maternal level and infant irritability per labeling and LactMed. |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
- Serial serum theophylline per label—especially after dose changes, interactions, or toxicity signs
- Basic metabolic panel and electrolytes when prolonged therapy, vomiting, or toxicity workup
- Document meal pattern, new antibiotics, smoking changes, and time of last dose with every level
Patient teaching
- Report nausea, vomiting (especially repeated episodes), palpitations, tremor, restlessness, or confusion immediately—do not take the next scheduled dose until instructed
- Take ER theophylline at the same time daily; keep meal patterns consistent; avoid sudden high-fat meals with Theo-24
- Do not chew or crush ER capsules; do not add extra doses for breathing difficulty without prescriber approval
- Tell the team about new antibiotics, smoking changes, or fever—these alter drug levels
- Limit extra caffeine unless prescriber approves; methylxanthines add together
The Hold Rule
- Repetitive vomiting or other signs consistent with theophylline toxicity—even if another cause is suspected—hold additional doses and obtain serum theophylline level immediately
- Serum theophylline >20 mcg/mL or prescriber/pharmacy hold parameter reached
- Known hypersensitivity to theophylline
- Unclear ER product, strength, or schedule; patient took extra dose at home
- New generalized seizure, intractable vomiting, or hemodynamically unstable arrhythmia while on therapy
Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.
Clinical practice integration and workflow
Build serum theophylline timing into handoff whenever oral ER therapy runs—especially after new antibiotics or diet changes. Never give an extra ER dose for persistent wheezing when vomiting or rising levels suggest toxicity.
1. Check-before-you-give protocol
- Confirm patient identity, drug name, ER strength, route, and scheduled time
- Verify methylxanthine exposure from all sources and most recent theophylline level
- Reconcile new antibiotics, cimetidine, phenytoin, rifampin, smoking status, and meal instructions
- Independent double-check when initiating or changing ER theophylline dose
2. High-alert and safety badge
Narrow therapeutic index — level-guided oral therapyIndividual clearance varies fourfold; population starting doses can be sub-therapeutic or toxic in a given patient. Levels are mandatory for safe titration.
3. Hold and question rules
- Hold next scheduled dose for repetitive vomiting before antiemetics alone
- Question any dose increase when the level is not sub-therapeutic (<10 mcg/mL) per labeling
- Escalate when level crosses 20 mcg/mL or seizure/arrhythmia occurs
4. Critical teach-back questions
- “What symptoms should you report right away?” Repetitive vomiting, tremor, palpitations, confusion.
- “Why are we drawing blood?” To keep theophylline in a safe range and prevent seizures or arrhythmias.
5. Care coordination
Pharmacy: Level interpretation, interaction checks, and dose adjustments when clearance changes.
Respiratory / medical team: Coordinate with inhaled bronchodilators and steroids; reassess need for continued oral methylxanthine as symptoms improve.
🧠 Quick mental checklist
- Latest level and next draw due?
- Any repetitive vomiting, tremor, or confusion?
- New macrolide, fluoroquinolone, or cimetidine?
- High-fat meal change with Theo-24?
- Correct ER strength and single methylxanthine source?
Theophylline NCLEX practice questions
Rehearse NCLEX-style clinical judgment practice for oral extended-release theophylline using a tabbed outpatient-to-inpatient case (MAR, labs, vitals, nursing notes), then priority action, cue recognition (SATA), trend interpretation, matrix urgency sorting, level judgment, and overdose-management cloze—recognise cues → analyse → prioritise → act → evaluate outcomes.
Select a tab to view MAR, labs, vitals, and nursing note details for this case.
- Theo-24 400 mg PO daily — 0800 (home med continued on admission)
- Ciprofloxacin 500 mg PO BID — started yesterday for COPD exacerbation
- Albuterol nebulizer q4h PRN; prednisone 40 mg PO daily
- Scheduled theophylline dose due 0800 tomorrow — not yet given (held pending level)
- Admission (pre-cipro): 13 mcg/mL
- Day 2 trough: 17 mcg/mL
- Day 3 trough (pending): 21 mcg/mL — phlebotomy 0700
- 0730: HR 112, BP 128/76, RR 20, SpO2 94% on 2 L NC, temp 37.4 °C
- Patient reports nausea; vomited twice since midnight
- 68-year-old with COPD exacerbation; Theo-24 at home 6 months
- 0645: Ate large fast-food breakfast (high fat) before level draw
- 0720: Fine hand tremor; anxious; refuses scheduled Theo-24 until “stomach settles”
Answer key & rationale
Frequently asked questions
What serum theophylline level is considered toxic?
At concentrations above 20 mcg/mL, adverse reactions increase—including persistent vomiting, arrhythmias, and intractable seizures. Target average steady-state concentrations are 10–15 mcg/mL per labeling.
When should a nurse hold theophylline doses?
Hold additional doses whenever repetitive vomiting or other toxicity signs appear—even if another cause is suspected—and obtain a serum theophylline concentration immediately.
Can a high-fat meal raise theophylline levels?
Yes. Theo-24 labeling warns that a high-fat meal can increase peak concentration and may raise levels above 20 mcg/mL. Teach consistent meal timing.
Is there a single antidote for theophylline overdose?
No. Management includes stopping the drug, supportive care, activated charcoal, benzodiazepines for seizures, and hemodialysis or hemoperfusion when indicated. Contact local poison control / toxicology per facility protocol.
Which drugs raise theophylline levels?
Labeling cites cimetidine (~70% increase), erythromycin (~35%), and ciprofloxacin (~40%). Phenytoin and rifampin decrease levels. Reconcile antibiotics at every handoff.
References
- U.S. National Library of Medicine. THEO-24 (theophylline) capsule, extended release — Full prescribing information. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a108fa0-c230-475f-be93-6f864b98a410
- U.S. National Library of Medicine. Theophylline extended-release tablets — Full prescribing information. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6ca5cc9-4e5e-40cf-a36e-227aa4cb55c6
- StatPearls. Theophylline. NCBI Bookshelf.https://www.ncbi.nlm.nih.gov/books/NBK532962/
- National Heart, Lung, and Blood Institute. Asthma. NIH.https://www.nhlbi.nih.gov/health/asthma
- Drugs and Lactation Database (LactMed). Theophylline. NIH.https://www.ncbi.nlm.nih.gov/books/NBK501109/
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.